176 related articles for article (PubMed ID: 8844816)
1. Enhancement of rat liver cell foci development by combined treatment with heterocyclic amines at low doses.
Ito N; Hasegawa R; Asakawa E; Hirose M; Imaida K; Hagiwara A
Princess Takamatsu Symp; 1995; 23():251-9. PubMed ID: 8844816
[TBL] [Abstract][Full Text] [Related]
2. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses.
Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N
Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065
[TBL] [Abstract][Full Text] [Related]
3. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
Hirose M; Futakuchi M; Tanaka H; Orita SI; Ito T; Miki T; Shirai T
Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
[TBL] [Abstract][Full Text] [Related]
4. Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat.
Hasegawa R; Yoshimura I; Imaida K; Ito N; Shirai T
Jpn J Cancer Res; 1996 Nov; 87(11):1125-33. PubMed ID: 9045941
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenic risk of heterocyclic amines in combination - assessment with a liver initiation model.
Hirata A; Tsukamoto T; Sakai H; Takasu S; Ban H; Imai T; Totsuka Y; Nishigaki R; Wakabayashi K; Yanai T; Masegi T; Tatematsu M
Food Chem Toxicol; 2008 Jun; 46(6):2003-9. PubMed ID: 18331778
[TBL] [Abstract][Full Text] [Related]
7. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of hepatocarcinogenesis by combined administration of food-derived heterocyclic amines at low doses in the rat.
Hasegawa R; Kato T; Hirose M; Takahashi S; Shirai T; Ito N
Food Chem Toxicol; 1996; 34(11-12):1097-101. PubMed ID: 9119321
[TBL] [Abstract][Full Text] [Related]
9. Synergistic enhancement of glutathione S-transferase placental form-positive hepatic foci development in diethylnitrosamine-treated rats by combined administration of five heterocyclic amines at low doses.
Hasegawa R; Shirai T; Hakoi K; Takaba K; Iwasaki S; Hoshiya T; Ito N; Nagao M; Sugimura T
Jpn J Cancer Res; 1991 Dec; 82(12):1378-84. PubMed ID: 1778761
[TBL] [Abstract][Full Text] [Related]
10. Dietary modulation of the carcinogenicity of the heterocyclic amines.
Weisburger JH; Rivenson A; Kingston DG; Wilkins TD; Van Tassell RL; Nagao M; Sugimura T; Hara Y
Princess Takamatsu Symp; 1995; 23():240-50. PubMed ID: 8844815
[TBL] [Abstract][Full Text] [Related]
11. Suppression of glutathione S-transferase placental form-positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa.
Takekoshi H; Mizoguchi T; Komasa Y; Chubachi H; Inoue Y; Imanishi H; Nakano M
Oncol Rep; 2005 Aug; 14(2):409-14. PubMed ID: 16012723
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
[TBL] [Abstract][Full Text] [Related]
13. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Lee YS; Nishikawa A
J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
[TBL] [Abstract][Full Text] [Related]
14. Medium-term bioassays for carcinogenicity of chemical mixtures.
Ito N; Imaida K; Hirose M; Shirai T
Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1331-6. PubMed ID: 9860889
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of GST-P positive liver cell foci development by a medium-term carcinogenicity bioassay using repeated administration of D-galactosamine.
Kim HC; Lee YS; Furukawa F; Nishikawa A; Takahashi M
Cancer Lett; 1995 Nov; 98(1):71-6. PubMed ID: 8529208
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Hasegawa R; Takahashi S; Shirai T; Iwasaki S; Kim DJ; Ochiai M; Nagao M; Sugimura T; Ito N
Carcinogenesis; 1992 Aug; 13(8):1427-31. PubMed ID: 1499093
[TBL] [Abstract][Full Text] [Related]
17. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
[TBL] [Abstract][Full Text] [Related]
18. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
[TBL] [Abstract][Full Text] [Related]
19. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
